Pharmaquant Insights Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -2.64%
(FY 2023)
- Profit 8.82%
(FY 2023)
- Ebitda -14.48%
(FY 2023)
- Net Worth 84.97%
(FY 2023)
- Total Assets 17.17%
(FY 2023)
About Pharmaquant Insights
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Subrata Bhattacharyya, Biswanath Bhattacharya, and Vimlesh Chaurasia serve as directors at the Company.
- CIN/LLPIN
U74999WB2019PTC230939
- Company No.
230939
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Mar 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Pharmaquant Insights?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vimlesh Chaurasia  | Director | 21-Dec-2022 | Current |
| Subrata Bhattacharyya | Director | 15-Mar-2019 | Current |
| Biswanath Bhattacharya | Additional Director | Current |
Financial Performance and Corporate Structure Insights of Pharmaquant Insights.
Pharmaquant Insights Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.64% decrease. The company also saw a slight improvement in profitability, with a 8.82% increase in profit. The company's net worth Soared by an impressive increase of 84.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmaquant Insights?
In 2023, Pharmaquant Insights had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Magically Be-You-Tiful Cosmetics Private LimitedActive 8 months 15 days
Vimlesh Chaurasia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmaquant Insights?
Pharmaquant Insights has a workforce of 12 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmaquant Insights, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmaquant Insights's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
